Company Interview / Medibank says its results are healthier than they look

Key points:

Medibank (ASX:MPL) reports a net profit decline but improved operating profit by 6.8% Strong growth in health insurance, especially among younger Australians taking up policies Rising premiums pose affordability challenges; focus on delivering customer value and prevention programmes Calls for broader private health system reform and innovation to control costs and maintain sustainability

Medibank (ASX:MPL) has reported an 11% decline in net profit after tax to just under $303 million, attributed in part to lower student visa approvals impacting its non-resident growth. David Koczkar states that while the headline figure is down, operating profit has risen 6.8%, which he considers a strong result. Koczkar highlights robust momentum in the health insurance segment and a 28% lift in Medibank Health as key positives. The company also achieved resident policy growth of 38,000, reflecting effective brand and customer engagement.

Koczkar maintains that the consumer market remains resilient, with private health insurance uptake at record highs, especially among younger Australians. He observes that despite premium pressures driven by government-approved increases, many policyholders continue to prioritise health and perceive value in private cover, even as some choose to downgrade to more affordable options. Medibank is staying focused on its $10 million productivity program and delivering greater value to its customers by reducing out-of-pocket expenses and investing in preventive health programmes.

Looking ahead, Koczkar identifies the need for system reform to sustain affordability amid persistent health inflation. He calls for greater investment in prevention, community-based care, and virtual healthcare solutions to ensure the sector’s long-term viability. Medibank’s dual-brand portfolio, including the H.M. offering, is seen as well-positioned to address evolving customer needs.